Published in Structure on July 26, 2012
An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol (2015) 3.74
Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat Rev Microbiol (2014) 3.48
The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. RNA Biol (2013) 2.44
Structural biology. Crystal structure of the CRISPR RNA-guided surveillance complex from Escherichia coli. Science (2014) 2.09
Structural biology. Crystal structure of a CRISPR RNA-guided surveillance complex bound to a ssDNA target. Science (2014) 2.01
Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of Thermus thermophilus. Mol Cell (2013) 1.96
Classification and evolution of type II CRISPR-Cas systems. Nucleic Acids Res (2014) 1.91
Comparative genomics of defense systems in archaea and bacteria. Nucleic Acids Res (2013) 1.82
The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature (2016) 1.64
Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands. PLoS Genet (2013) 1.63
Type I-E CRISPR-cas systems discriminate target from non-target DNA through base pairing-independent PAM recognition. PLoS Genet (2013) 1.56
CRISPR interference: a structural perspective. Biochem J (2013) 1.48
CRISPRTarget: bioinformatic prediction and analysis of crRNA targets. RNA Biol (2013) 1.46
A ruler protein in a complex for antiviral defense determines the length of small interfering CRISPR RNAs. J Biol Chem (2013) 1.35
Crystal structure of the RNA-guided immune surveillance Cascade complex in Escherichia coli. Nature (2014) 1.33
Function and regulation of clustered regularly interspaced short palindromic repeats (CRISPR) / CRISPR associated (Cas) systems. Viruses (2012) 1.27
Genetic characterization of antiplasmid immunity through a type III-A CRISPR-Cas system. J Bacteriol (2013) 1.22
Double-stranded endonuclease activity in Bacillus halodurans clustered regularly interspaced short palindromic repeats (CRISPR)-associated Cas2 protein. J Biol Chem (2012) 1.19
The CRISPR-associated gene cas2 of Legionella pneumophila is required for intracellular infection of amoebae. MBio (2013) 1.18
CRISPRmap: an automated classification of repeat conservation in prokaryotic adaptive immune systems. Nucleic Acids Res (2013) 1.16
Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression. Nucleic Acids Res (2014) 1.13
Molecular mechanisms of CRISPR-mediated microbial immunity. Cell Mol Life Sci (2014) 1.13
Structure of the Cmr2-Cmr3 subcomplex of the Cmr RNA silencing complex. Structure (2013) 1.11
In vivo protein interactions and complex formation in the Pectobacterium atrosepticum subtype I-F CRISPR/Cas System. PLoS One (2012) 1.07
The structural biology of CRISPR-Cas systems. Curr Opin Struct Biol (2015) 1.07
A complex of Cas proteins 5, 6, and 7 is required for the biogenesis and stability of clustered regularly interspaced short palindromic repeats (crispr)-derived rnas (crrnas) in Haloferax volcanii. J Biol Chem (2014) 1.02
The three major types of CRISPR-Cas systems function independently in CRISPR RNA biogenesis in Streptococcus thermophilus. Mol Microbiol (2014) 1.02
Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3. Proc Natl Acad Sci U S A (2014) 1.00
Programmable plasmid interference by the CRISPR-Cas system in Thermococcus kodakarensis. RNA Biol (2013) 0.96
Staphylococcus epidermidis Csm1 is a 3'-5' exonuclease. Nucleic Acids Res (2013) 0.96
Structure and RNA-binding properties of the type III-A CRISPR-associated protein Csm3. RNA Biol (2013) 0.95
CRISPR-Cas: biology, mechanisms and relevance. Philos Trans R Soc Lond B Biol Sci (2016) 0.93
Nucleic acid binding surface and dimer interface revealed by CRISPR-associated CasB protein structures. FEBS Lett (2012) 0.92
Structure of the archaeal Cascade subunit Csa5: relating the small subunits of CRISPR effector complexes. RNA Biol (2013) 0.90
Structure of a dimeric crenarchaeal Cas6 enzyme with an atypical active site for CRISPR RNA processing. Biochem J (2013) 0.90
Identifying and Visualizing Functional PAM Diversity across CRISPR-Cas Systems. Mol Cell (2016) 0.89
Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus. RNA (2015) 0.86
Role of the Streptococcus mutans CRISPR-Cas systems in immunity and cell physiology. J Bacteriol (2014) 0.85
Structural Principles of CRISPR RNA Processing. Structure (2014) 0.85
Current and future prospects for CRISPR-based tools in bacteria. Biotechnol Bioeng (2015) 0.83
Active site plasticity enables metal-dependent tuning of Cas5d nuclease activity in CRISPR-Cas type I-C system. Nucleic Acids Res (2013) 0.83
CRISPRstrand: predicting repeat orientations to determine the crRNA-encoding strand at CRISPR loci. Bioinformatics (2014) 0.83
Comparative analysis ofCas6b processing and CRISPR RNA stability. RNA Biol (2013) 0.83
The role of Cas8 in type I CRISPR interference. Biosci Rep (2015) 0.81
Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex. Extremophiles (2016) 0.81
Structure Principles of CRISPR-Cas Surveillance and Effector Complexes. Annu Rev Biophys (2015) 0.80
The Adaptive Immune System of Haloferax volcanii. Life (Basel) (2015) 0.80
Defense systems up: structure of subtype I-C/Dvulg CRISPR/Cas. Structure (2012) 0.79
Controlling mRNA stability and translation with the CRISPR endoribonuclease Csy4. RNA (2015) 0.77
DNA Targeting by a Minimal CRISPR RNA-Guided Cascade. Mol Cell (2016) 0.77
Interference activity of a minimal Type I CRISPR-Cas system from Shewanella putrefaciens. Nucleic Acids Res (2015) 0.76
Functional Analysis of Porphyromonas gingivalis W83 CRISPR-Cas Systems. J Bacteriol (2015) 0.76
Characterization of CRISPR RNA transcription by exploiting stranded metatranscriptomic data. RNA (2016) 0.75
Crystallization and preliminary X-ray diffraction analysis of the Cmr2-Cmr3 subcomplex in the CRISPR-Cas RNA-silencing effector complex. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.75
Molecular determinants for CRISPR RNA maturation in the Cas10-Csm complex and roles for non-Cas nucleases. Nucleic Acids Res (2017) 0.75
Structural analyses of the CRISPR protein Csc2 reveal the RNA-binding interface of the type I-D Cas7 family. RNA Biol (2014) 0.75
Extensive Mobilome-Driven Genome Diversification in Mouse Gut-Associated Bacteroides vulgatus mpk. Genome Biol Evol (2016) 0.75
Primary processing of CRISPR RNA by the endonuclease Cas6 in Staphylococcus epidermidis. FEBS Lett (2015) 0.75
Survival and Evolution of CRISPR-Cas System in Prokaryotes and Its Applications. Front Immunol (2016) 0.75
crRNAs in Porphyromonas gingivalis CRISPR-Cas I-C system. J Bacteriol (2017) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr (2010) 108.52
Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res (2003) 77.89
Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol (1995) 46.37
Automated MAD and MIR structure solution. Acta Crystallogr D Biol Crystallogr (1999) 41.65
CRISPR provides acquired resistance against viruses in prokaryotes. Science (2007) 29.74
CRISPR/Cas, the immune system of bacteria and archaea. Science (2010) 18.72
Small CRISPR RNAs guide antiviral defense in prokaryotes. Science (2008) 17.79
CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature (2011) 17.38
RNA-guided genetic silencing systems in bacteria and archaea. Nature (2012) 17.12
Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol (2011) 17.11
A new generation of the IMAGIC image processing system. J Struct Biol (1996) 12.57
A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes. PLoS Comput Biol (2005) 11.82
A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol Direct (2006) 11.31
RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell (2009) 11.12
Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol (2005) 11.05
Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology (2005) 10.20
CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology (2005) 9.83
Macromolecular TLS refinement in REFMAC at moderate resolutions. Methods Enzymol (2003) 9.69
Regulatory RNAs in bacteria. Cell (2009) 9.57
CRISPR--a widespread system that provides acquired resistance against phages in bacteria and archaea. Nat Rev Microbiol (2008) 8.91
Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard. Acta Crystallogr D Biol Crystallogr (2007) 7.72
CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat Rev Genet (2010) 7.47
CRISPR/Cas system and its role in phage-bacteria interactions. Annu Rev Microbiol (2010) 7.15
Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes. Genes Dev (2008) 7.09
Sequence- and structure-specific RNA processing by a CRISPR endonuclease. Science (2010) 6.79
Structural basis for CRISPR RNA-guided DNA recognition by Cascade. Nat Struct Mol Biol (2011) 6.02
CRISPR-based adaptive and heritable immunity in prokaryotes. Trends Biochem Sci (2009) 5.54
Structures of the RNA-guided surveillance complex from a bacterial immune system. Nature (2011) 4.92
The CRISPR system: small RNA-guided defense in bacteria and archaea. Mol Cell (2010) 4.60
Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems. Biol Direct (2011) 3.92
Interaction of the Cas6 riboendonuclease with CRISPR RNAs: recognition and cleavage. Structure (2011) 3.58
Structural and functional characterization of an archaeal clustered regularly interspaced short palindromic repeat (CRISPR)-associated complex for antiviral defense (CASCADE). J Biol Chem (2011) 2.86
An RNA-induced conformational change required for CRISPR RNA cleavage by the endoribonuclease Cse3. Nat Struct Mol Biol (2011) 2.49
Recognition and maturation of effector RNAs in a CRISPR interference pathway. Nat Struct Mol Biol (2011) 2.47
Crystal structure of hypothetical protein TTHB192 from Thermus thermophilus HB8 reveals a new protein family with an RNA recognition motif-like domain. Protein Sci (2006) 2.29
Crystallization of RNA and RNA-protein complexes. Methods (2004) 1.48
Envelope stress is a trigger of CRISPR RNA-mediated DNA silencing in Escherichia coli. Mol Microbiol (2010) 1.33
Single particle electron microscopy reconstruction of the exosome complex using the random conical tilt method. J Vis Exp (2011) 0.93
The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest (2005) 3.56
PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR. J Clin Invest (2007) 3.54
Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science (2010) 2.99
Seasonal patterns in monthly hemoglobin A1c values. Am J Epidemiol (2005) 2.93
Flavonoids: promising anticancer agents. Med Res Rev (2003) 2.43
Prehypertension and black-white contrasts in cardiovascular risk in young adults: Bogalusa Heart Study. J Hypertens (2009) 2.20
Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. J Biol Chem (2003) 1.97
ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury. J Clin Invest (2008) 1.92
Evaluation of published single nucleotide polymorphisms associated with acute GVHD. Blood (2012) 1.88
A three-channel microfluidic device for generating static linear gradients and its application to the quantitative analysis of bacterial chemotaxis. Lab Chip (2005) 1.85
Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development. J Virol (2008) 1.76
Engineering the spatial organization of metabolic enzymes: mimicking nature's synergy. Curr Opin Biotechnol (2008) 1.76
Architecture of the yeast Rrp44 exosome complex suggests routes of RNA recruitment for 3' end processing. Proc Natl Acad Sci U S A (2007) 1.71
Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism. J Biol Chem (2003) 1.69
Genetic selection for protein solubility enabled by the folding quality control feature of the twin-arginine translocation pathway. Protein Sci (2006) 1.61
Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens. Cancer Res (2003) 1.56
Crystal structures of the SAM-III/S(MK) riboswitch reveal the SAM-dependent translation inhibition mechanism. Nat Struct Mol Biol (2008) 1.54
Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am J Surg Pathol (2012) 1.53
Electrophysiologic effects of nicorandil on the guinea pig long QT1 syndrome model. J Cardiovasc Electrophysiol (2004) 1.49
Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One (2009) 1.49
Mediation of multiple pathways regulating cell proliferation, migration, and apoptosis in the human malignant glioma cell line U87MG via unphosphorylated STAT1: laboratory investigation. J Neurosurg (2013) 1.44
Delivery of foreign antigens by engineered outer membrane vesicle vaccines. Proc Natl Acad Sci U S A (2010) 1.43
Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice. FASEB J (2010) 1.41
The crystal structure of the signal recognition particle in complex with its receptor. Science (2011) 1.41
Engineered genetic selection links in vivo protein folding and stability with asparagine-linked glycosylation. Biotechnol J (2013) 1.39
The ribosomal exit tunnel as a target for optimizing protein expression in Escherichia coli. Biotechnol J (2012) 1.39
Glycoarrays with engineered phages displaying structurally diverse oligosaccharides enable high-throughput detection of glycan-protein interactions. Biotechnol J (2014) 1.38
Collective bacterial dynamics revealed using a three-dimensional population-scale defocused particle tracking technique. Appl Environ Microbiol (2006) 1.34
Strain distribution pattern of susceptibility to immune-mediated nephritis. J Immunol (2004) 1.34
Envelope stress is a trigger of CRISPR RNA-mediated DNA silencing in Escherichia coli. Mol Microbiol (2010) 1.33
An engineered pathway for the formation of protein disulfide bonds. Science (2004) 1.29
Export pathway selectivity of Escherichia coli twin arginine translocation signal peptides. J Biol Chem (2007) 1.28
DNA-guided assembly of biosynthetic pathways promotes improved catalytic efficiency. Nucleic Acids Res (2011) 1.28
RNA-mediated interaction between the peptide-binding and GTPase domains of the signal recognition particle. Nat Struct Mol Biol (2005) 1.24
T box RNA decodes both the information content and geometry of tRNA to affect gene expression. Proc Natl Acad Sci U S A (2013) 1.23
Engineered bacterial outer membrane vesicles with enhanced functionality. J Mol Biol (2008) 1.20
Laboratory evolution of fast-folding green fluorescent protein using secretory pathway quality control. PLoS One (2008) 1.19
Double-stranded endonuclease activity in Bacillus halodurans clustered regularly interspaced short palindromic repeats (CRISPR)-associated Cas2 protein. J Biol Chem (2012) 1.19
Expanding the roles for pregnane X receptor in cancer: proliferation and drug resistance in ovarian cancer. Clin Cancer Res (2008) 1.18
Papillary squamous cell carcinoma of the head and neck: clinicopathologic and molecular features with special reference to human papillomavirus. Am J Surg Pathol (2013) 1.18
Elastic coupling between RNA degradation and unwinding by an exoribonuclease. Science (2012) 1.16
SAM recognition and conformational switching mechanism in the Bacillus subtilis yitJ S box/SAM-I riboswitch. J Mol Biol (2010) 1.15
Epidemiology of myeloproliferative neoplasms in the United States. Leuk Lymphoma (2013) 1.14
Snail involves in the transforming growth factor β1-mediated epithelial-mesenchymal transition of retinal pigment epithelial cells. PLoS One (2011) 1.14
Alleviation of gut inflammation by Cdx2/Pxr pathway in a mouse model of chemical colitis. PLoS One (2012) 1.14
Following the path of a twin-arginine precursor along the TatABC translocase of Escherichia coli. J Biol Chem (2008) 1.13
Geographical, spatial, and temporal distributions of multiple indoor air pollutants in four Chinese provinces. Environ Sci Technol (2005) 1.12
A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis. Int J Cancer (2012) 1.11
Crystal structure of clustered regularly interspaced short palindromic repeats (CRISPR)-associated Csn2 protein revealed Ca2+-dependent double-stranded DNA binding activity. J Biol Chem (2011) 1.11
Secretion of the chlamydial virulence factor CPAF requires the Sec-dependent pathway. Microbiology (2010) 1.08
Relation of childhood risk factors to left ventricular hypertrophy (eccentric or concentric) in relatively young adulthood (from the Bogalusa Heart Study). Am J Cardiol (2008) 1.08
Computationally identifying virulence factors based on KEGG pathways. Mol Biosyst (2013) 1.08
An engineered eukaryotic protein glycosylation pathway in Escherichia coli. Nat Chem Biol (2012) 1.07
Efficient isolation of soluble intracellular single-chain antibodies using the twin-arginine translocation machinery. J Mol Biol (2008) 1.06
An essential role for the DnaK molecular chaperone in stabilizing over-expressed substrate proteins of the bacterial twin-arginine translocation pathway. J Mol Biol (2007) 1.04
Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study. BMC Infect Dis (2006) 1.04
RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activity. J Infect Dis (2011) 1.03
Discovery of amyloid-beta aggregation inhibitors using an engineered assay for intracellular protein folding and solubility. Protein Sci (2009) 1.03
Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects. Nutr Metab (Lond) (2006) 1.02
Linking molecular diagnostics to molecular therapeutics: targeting the PI3K pathway in breast cancer. Semin Oncol (2003) 1.01
Production of secretory and extracellular N-linked glycoproteins in Escherichia coli. Appl Environ Microbiol (2010) 1.01
Characterization of an avian influenza virus of subtype H7N2 isolated from chickens in northern China. Virus Genes (2006) 1.01
In vivo and in vitro characterization of a first-in-class novel azole analog that targets pregnane X receptor activation. Mol Pharmacol (2011) 1.01
Reoperation after lumbar disc surgery in two hundred and seven patients. Int Orthop (2013) 1.01
Genome-wide analysis of ZmDREB genes and their association with natural variation in drought tolerance at seedling stage of Zea mays L. PLoS Genet (2013) 1.01
Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women. PLoS One (2009) 1.00
Genetic toggling of alkaline phosphatase folding reveals signal peptides for all major modes of transport across the inner membrane of bacteria. J Biol Chem (2008) 1.00
Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program. Eur J Heart Fail (2009) 1.00
Visualizing interactions along the Escherichia coli twin-arginine translocation pathway using protein fragment complementation. PLoS One (2010) 0.99
Structure and assembly of the essential RNA ring component of a viral DNA packaging motor. Proc Natl Acad Sci U S A (2011) 0.99
Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome. Fertil Steril (2008) 0.98
Astragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levels. PLoS One (2013) 0.98
Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders. Am J Clin Pathol (2013) 0.98
Identification of a twin-arginine translocation system in Pseudomonas syringae pv. tomato DC3000 and its contribution to pathogenicity and fitness. J Bacteriol (2005) 0.98
Predicting multiallelic genes using unphased and flanking single nucleotide polymorphisms. Genet Epidemiol (2010) 0.97
Adiponectin, acylation stimulating protein and complement C3 are altered in obesity in very young children. Clin Endocrinol (Oxf) (2005) 0.96
Clinical characteristics and treatment of angiomatous meningiomas: a report of 27 cases. Int J Clin Exp Pathol (2013) 0.96
Assessing quality of diabetes care by measuring longitudinal changes in hemoglobin A1c in the Veterans Health Administration. Health Serv Res (2005) 0.96
The beta2 integrin CD11c distinguishes a subset of cytotoxic pulmonary T cells with potent antiviral effects in vitro and in vivo. Respir Res (2005) 0.95
Proportion of treatment effect (PTE) explained by a surrogate marker. Stat Med (2003) 0.95
Stat3 inhibition augments the immunogenicity of B-cell lymphoma cells, leading to effective antitumor immunity. Cancer Res (2012) 0.94
Structural determinants for geometry and information decoding of tRNA by T box leader RNA. Structure (2013) 0.94
Therapeutic and immune effects of 5-aminolevulinic acid photodynamic therapy on UVB-induced squamous cell carcinomas in hairless mice. Exp Dermatol (2013) 0.93
Targeting PI3K-AKT pathway for cancer therapy. Rev Clin Exp Hematol (2003) 0.93
Expanding the glycoengineering toolbox: the rise of bacterial N-linked protein glycosylation. Trends Biotechnol (2013) 0.93
Mitophagy enhances oncolytic measles virus replication by mitigating DDX58/RIG-I-like receptor signaling. J Virol (2014) 0.93
The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity. Melanoma Res (2013) 0.92
Sodium transport in the choroid plexus and salt-sensitive hypertension. Hypertension (2009) 0.92
Insulinoma-associated antigen-1 zinc-finger transcription factor promotes pancreatic duct cell trans-differentiation. Endocrinology (2010) 0.92
Enhanced CD8 T cell cross-presentation by macrophages with targeted disruption of STAT3. Immunol Lett (2010) 0.92
Nucleic acid binding surface and dimer interface revealed by CRISPR-associated CasB protein structures. FEBS Lett (2012) 0.92
Chlamydia trachomatis secretion of an immunodominant hypothetical protein (CT795) into host cell cytoplasm. J Bacteriol (2011) 0.92
Variable sequences outside the SAM-binding core critically influence the conformational dynamics of the SAM-III/SMK box riboswitch. J Mol Biol (2011) 0.92
Correlates of common carotid artery lumen diameter in black and white younger adults: the Bogalusa Heart Study. Stroke (2009) 0.91